Medicine
Sorilux 50 mcg/g foam
Sorilux 50 mcg/g foam is a prescription medicine containing Calcipotriene for topical use, marketed by Mayne Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20ºC to 25°C (68°F to 77°F), excursions permitted to 15°C – 30°C…
Key facts
- Active ingredient (INN)
- Calcipotriene
- Brand
- Sorilux
- Strength
- 50 mcg/g
- Dosage form
- Foam
- Route
- Topical
- Packs
- 1 can
- Marketing authorisation holder
- Mayne Pharma
- Manufacturer
- Mayne Pharma
- Origin register
- US FDA, United States
- Storage
- Store at 20ºC to 25°C (68°F to 77°F), excursions permitted to 15°C – 30°C (59°F – 86°F). Do not expose to heat or store at temperatures above 120°F (49°C).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D05AX02 Calcipotriene
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 11 April 2017
- Identifiers
- RxCUI 1020035, 1020039DailyMed set ID 51f208d0-7b3f-44cc-8bed-92fa3d2e7bbeNDC 51862-376Application NDA022563
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 can in 1 carton / 120 g in 1 can | 51862-376-12 | Mayne Pharma | 11 April 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 December 1993 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Calcipotriene 50 mcg/g foam.
Other strengths and forms of Calcipotriene
Clinical summary
Calcipotriene is a vitamin D analog indicated for the treatment of plaque psoriasis in adults. It is available as ointment, cream and foam for topical use. MedsAcross supplies Calcipotriene for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CalcipotrieneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- calcipotriene prescribing information (Prasco Laboratories) · U.S. National Library of Medicine, DailyMed
Need Sorilux 50 mcg/g foam for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.